GlassScriptPhysician profile
Amit Trivedi
NPI 1386701282
$241,792.71
in general payments reported to CMS, 2019-2025
19 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $39K · 2021: $24K · 2022: $13K · 2023: $50K · 2024: $25K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $83K · Travel and Lodging: $15K · Food and Beverage: $4,127 · Education: $7.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,021.21 |
| Travel and Lodging | $15,255.50 |
| Food and Beverage | $4,126.58 |
| Education | $7.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $207,403.38 | 2019-2025 | Senhance |
| Covidien LP | $19,274.00 | 2019-2020 | |
| Medtronic, INC. | $10,860.89 | 2021-2025 | Signia, Progrip, Endo Stitch |
| W. L. Gore & Associates, INC. | $1,668.61 | 2023-2025 | Seamguard, Gore Synecor Biomaterial |
| Stryker Corporation | $1,349.68 | 2021-2022 | |
| Ethicon US, LLC | $500.03 | 2019-2023 | Echelon Flex |
| Teleflex LLC | $155.01 | 2021-2024 | Titan Sgs |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $118.94 | 2024 | |
| Davol INC. | $105.72 | 2025 | Avitene Ultrafoam, Channel Drain |
| Integra Lifesciences Corporation | $69.81 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Conmed Corporation | $69.65 | 2024 | Airseal |
| Novo Nordisk INC | $35.61 | 2023 | Wegovy |
| Baxter Healthcare | $32.51 | 2022 | |
| Kerecis Limited | $32.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Daiichi Sankyo INC. | $31.60 | 2021-2023 | Injectafer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $29.37 | 2019-2023 | Nascobal |
| Becton, Dickinson and Company | $25.08 | 2025 | Phasix Mesh |
| Smith+Nephew, INC. | $15.72 | 2024 | Collagenase Santyl |
| Vivus LLC | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.